HLAVÁČKOVÁ, Eva, Zdenka KŘENOVÁ, Jaroslav ŠTĚRBA and Jiří LITZMAN. Immunology follow-up after rituximab treatment in pediatric non Hodgkin lymfoma patients (Immunology follow-up after rituximab treatment). In The 17th Biennial Meeting of the European Society for Immunodeficiencies (ESID 2018. 2018.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Immunology follow-up after rituximab treatment in pediatric non Hodgkin lymfoma patients
Authors HLAVÁČKOVÁ, Eva (203 Czech Republic, belonging to the institution), Zdenka KŘENOVÁ (203 Czech Republic), Jaroslav ŠTĚRBA (203 Czech Republic) and Jiří LITZMAN (203 Czech Republic, guarantor).
Edition The 17th Biennial Meeting of the European Society for Immunodeficiencies (ESID 2018, 2018.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30102 Immunology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/18:00105776
Organization unit Faculty of Medicine
Keywords in English NHL hypogammaglobulinemia children
Changed by Changed by: MUDr. Eva Hlaváčková, Ph.D., učo 15645. Changed: 21/1/2019 11:19.
Abstract
Rituximab treatment leads to absolute transitional CD19+ B lymphocytopenia. IgG decrease could be delayed after the B cell recovery in the periphery. Clinical and laboratory sights of antibody secondary deficiency should be regularly monitored.
Links
MUNI/A/0925/2017, interní kód MUName: Poruchy tvorby protilátek a komplementového systému
Investor: Masaryk University, Category A
PrintDisplayed: 30/5/2024 06:39